Skip to main content

Table 1 Anthropometrical and clinical characteristics of study population

From: Biochemical but not imaging parameters are predictive of outcome in septic shock: a pilot study

Variables

All subjects (n = 35)

Age (y)

59 (48; 60)

Gender (M)

21 (60%)

BMI (kg/m2)

25 (22; 29)

Risk Factors

 Smoking habit, n (%)

11 (31%)

 Hypertension, n (%)

18 (51%)

 Dyslipidemia, n (%)

10 (29%)

 Diabetes, n (%)

10 (29%)

 Previous cardiovascular disease, n (%)

5 (14%)

Predisposing factors

 Gastrointestinal diseases, n (%)

10 (29%)

 Autoimmune diseases, n (%)

1 (3%)

 Respiratory diseases, n (%)

7 (20%)

 Vascular surgery/limb iscaemia, n (%)

1 (3%)

 Genitourinary diseases, n (%)

5 (14%)

 Orthopedic/skeletal diseases, n (%)

1 (3%)

 Haematological diseases, n (%)

10 (29%)

Within 30 days mortality, n (%)

15 (43%)

SBP (mmHg)

120 (108; 134)

DBP (mmHg)

60 (55; 65)

MAP (mmHg)

80 (73; 86)

HR (beats/min)

96 (87; 116)

Epinephrine (ɣ/kg/min)

0.09 (0.04; 0.26)

Norepinephrine (ɣ/kg/min)

0.26 (0.12; 0.49)

TnT (ng/L)

91 (38; 193)

PCT (ng/mL)

34 (9; 100)

NT-ProBNP (ng/L)

12,324 (3135; 29,571)

Echocardiograghy values

 VTD (mL)

101 (62; 110)

 VTS (mL)

39 (31; 53)

 Dtd (mm)

45 (41; 51)

 EF (%)

55 (40; 60)

  1. Data are expressed as median and interquartile range (I-III) or as number and percentage. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, HR heart rate, TnT troponine T, PCT pro-calcitonin, NT-ProBNP pro b-type natriuretic peptide, VTD and VTS telediastolic and telesystolic volumes, EF ejection fraction